Liver Transplant Clinical Trials

Liver

Current Clinical Trials

Molecular profiling and donor and recipient pro inflammatory and alloimmune response
Principal Investigator: Abraham Shaked, MD, PhD
Sponsor: National Institutes of Health

Tissue and serum bank
Principal Investigator: Kim Olthoff, MD

Gene expression and regenerative pathways in donor livers
Principal Investigator: Kim Olthoff, MD
Sponsor: National Institutes of Health

Campath-1H and Tacrolimus followed by immunosuppression withdrawal in liver transplantation
Principal Investigator: Abraham Shaked, MD, PhD
Sponsor: Immune Tolerance Network

A phase II trial to assess the safety of immunosuppression withdrawal in liver transplant recipients with hepatitis C
Principal Investigator: Abraham Shaked, MD, PhD
Sponsor: Immune Tolerance Network

Validation of serum markers for the early detection of hepatocellular carcinoma (DCP)
Principal Investigator: K. Rajender Reddy, MD
Sponsor: National Cancer Institute

A2 ALL: adult to adult living donor liver transplant cohort study
Principal Investigator: Abraham Shaked, MD, PhD
Sponsor: National Institutes of Health

Clinical, immunologic and pharmacologic consequences of liver transplantation in people with HIV infection
Principal Investigator: Kim Olthoff, MD
Sponsor: National Institutes of Health

Comparative evaluation of inhibitor treatments in liver allograft recipients
Principal Investigator: K. Rajender Reddy, MD

Comparative safety and efficacy study of prophylactic interferon following liver transplantation for hepatitis C
Principal Investigator: K. Rajender Reddy, MD
Sponsor: National Institutes of Health

Safety and efficacy study of N-acetylcysteine in the treatment of acute liver failure not caused by acetaminophen in adult patients
Principal Investigator: K. Rajender Reddy, MD
Sponsor: National Institutes of Health

An observational database of patients who receive orthotopic liver transplantation (OLT) for hepatitis B
Principal Investigator: K. Rajender Reddy, MD

Comparison of HepeX-BTM, a mixture of two monoclonal antibodies, to hepatitis B immune globulin in patients who have received hepatic allografts for treatment of end-stage liver disease due to Hepatitis B virus infection
Principal Investigator: K. Rajender Reddy, MD

Intravenous Terlipressin in patients with Hepatorenal Syndrome Type I
Principal Investigator: K. Rajender Reddy, MD

For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.

For more information, please view our patient guide.


	Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.